An Investigation of Psilocybin on Behavioural and Cognitive Symptoms of Adults With Fragile X Syndrome
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05832255 |
|
Recruitment Status :
Suspended
(Indefinite hold due to protocol revisions relating to the exclusion criteria for concurrent medications.)
First Posted : April 27, 2023
Last Update Posted : May 8, 2024
|
Sponsor:
Nova Mentis Life Science Corp
Collaborator:
KGK Science Inc.
Information provided by (Responsible Party):
Nova Mentis Life Science Corp
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Suspended |
|---|---|
| Estimated Primary Completion Date : | May 2024 |
| Estimated Study Completion Date : | May 2024 |